Overview of Monoclonal Gammopathies From MGUS to Smoldering Myeloma

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

M. Kwok

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Indy Hematology Review

R. Birhiray

POEMS Syndrome Management

MyCancerHaven

R. Vij, D. Dingli

Lung Involvement in Amyloidosis

Houston Methodist

H. Huang

Experts Discuss the Management of Monoclonal Gammopathy of Renal Sig…

MyCancerHaven

R. Vij, N. Leung

Management of AL Amyloidosis

GRACE

S. Rajeeve

Updates on AL Amyloidosis Treatment: What’s New in 2024

Dana-Farber Cancer Institute

G. Bianchi

Indy Hematology Review 2023: Plasma Cell Neoplasms and Amyloidosis U…

Indy Hematology Review

M. Gertz

"You Have AL-Amyloidosis": Counseling Newly Diagnosed Patients

Morie Gertz

Treating Amyloidosis in 2024

MyCancerHaven

R. Vij, J. Zonder

AL Amyloidosis Treatment Updates

Yale Cancer Center

T. Parker

Experts Discuss Novel Antibodies for the Management of Amyloidosis

MyCancerHaven

R. Vij, S. Lentzsch

Renal AL Amyloid

Yale Cancer Center

R. Luciano

Interpreting a PYP Study for TTR Cardiac Amyloid

American Society of Nuclear Cardiology

P. Soman, M. Harinstein, S. Divakaran

Diagnosing AL Amyloidosis

GRACE

S. Rajeeve

2024 Updates on Myeloma Precursor Diseases and AL Amyloidosis

Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

S. Susanibar-Adaniya

FDA Perspective on New Therapies for Amyloidosis

Houston Methodist

R. Adigun

Amyloidosis: Pathophysiology

Houston Methodist

S. Ganguly

ASH 2023 Insights: "Daratumumab Monotherapy in Newly Diagnosed Stage…

Insights from 2023 ASH Annual Meeting

E. Kastritis

Current Treatment Options for AL Amyloidosis

Houston Methodist

K. Baker